Is Galanin a Promising Therapeutic Resource for Neural and Nonneural Diseases?
- 28 July 2020
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Drug Targets
- Vol. 21 (9) , 922-929
Abstract
Background: Galanin (GAL) constitutes a family of neuropeptides composed of four peptides: (i) galanin (GAL), (ii) galanin-message associated peptide (GAMP), (iii) galanin-like peptide (GALP), and (iv) alarin. GAL contains 29/30 amino acids, and its biological action occurs through the interactions with its various receptors (GALR1, GALR2, and GALR3). The neuropeptide GAL regulates several physiological and pathophysiological functions in the central nervous system, the peripheral nervous system, and the peripheral organs. GAL is secreted mainly by oligodendrocytes, astrocytes, and the gastrointestinal tract, and its effect depends on the interaction with its different receptors. These receptors are expressed mainly in the central, peripheral nervous systems and the intestines. Objective: The present review evaluates the role of GAL family in inflammatory diseases. An overview is given of the signaling and pharmacological effects due to the interaction between GAL and GALR in different cell types. The potential use of GAL as a therapeutic resource is critically discussed. Conclusion: GAL is suggested to have an anti-inflammatory function in some situations and a proinflammatory function in others. The literature on GAL is controversial and currently not conclusive. This could be due to the complexity of the metabolic network signaling induced by the interactions between GAL and GALR. In the next future, GAL might be a promising therapeutic resource for several diseases, but its practical use for disease control is presently not advisable.Keywords
This publication has 69 references indexed in Scilit:
- Galanin Receptors and LigandsFrontiers in Endocrinology, 2012
- Global Gene Expression Analysis Reveals Evidence for Decreased Lipid Biosynthesis and Increased Innate Immunity in Uninvolved Psoriatic SkinJournal of Investigative Dermatology, 2009
- Galanin Message-Associated Peptide Suppresses Growth and the Budded-to-Hyphal-Form Transition of Candida albicansAntimicrobial Agents and Chemotherapy, 2007
- Circulating acylated and total ghrelin and galanin in children with insulin‐treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal developmentClinical Endocrinology, 2005
- Distribution of galanin receptor 1 immunoreactivity in the rat stomach and small intestineJournal of Comparative Neurology, 2002
- Cloning and Expression of the Human Galanin Receptor GalR2Biochemical and Biophysical Research Communications, 1998
- Cloning and Quantification of Galanin-1 Receptor Expression by Mucosal Cells Lining the Human Gastrointestinal TractBiochemical and Biophysical Research Communications, 1996
- Occurrence and distribution of a newly discovered peptide, galanin, in the mammalian enteric nervous system.Gut, 1986
- A galanin-like peptide coexists in putative cholinergic somata of the septum-basal forebrain complex and in acetylcholinesterase-containing fibers and varicosities within the hippocampus in the owl monkey (aotus trivirgatus)Neuroscience Letters, 1986
- Galanin — a novel biologically active peptide from porcine intestineFEBS Letters, 1983